Hui-Sheng Chen
Quick facts
Marketed products
- Argatroban combined with rt-PA
- Butyphthalide combined with rtPA
- rtPA · Cardiovascular; Neurology
rtPA is a tissue plasminogen activator that converts plasminogen to plasmin, directly dissolving fibrin clots through fibrinolysis.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Hui-Sheng Chen
What are Hui-Sheng Chen's marketed drugs?
Top marketed products include Argatroban combined with rt-PA, Butyphthalide combined with rtPA, rtPA.
Related
- Argatroban combined with rt-PA
- Butyphthalide combined with rtPA
- rtPA · Cardiovascular; Neurology
- Sector hub: All tracked pharma companies